Analysis of the clinical characteristics of insulin autoimmune syndrome induced by methimazole

The number of case reports of insulin autoimmune syndrome (IAS) induced by methimazole (MMI) is increasing. The purpose of this study is to explore the clinical characteristics and provide a scientific reference for clinical diagnosis, treatment and prevention.

[1]  C. Mian,et al.  Insulin autoimmune syndrome: from diagnosis to clinical management. , 2018, Annals of translational medicine.

[2]  S. Pearce,et al.  2018 European Thyroid Association Guideline for the Management of Graves’ Hyperthyroidism , 2018, European Thyroid Journal.

[3]  M. Boscaro,et al.  Insulin autoimmune syndrome (Hirata’s disease) in an Italian patient: a case report and review of the literature , 2017, Clinical chemistry and laboratory medicine.

[4]  Фадеев Валентин Викторович,et al.  Review of American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. , 2017 .

[5]  A. Ismail.  The insulin autoimmune syndrome (IAS) as a cause of hypoglycaemia: an update on the pathophysiology, biochemical investigations and diagnosis , 2016, Clinical chemistry and laboratory medicine.

[6]  S. Rivkees,et al.  2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis. , 2016, Thyroid : official journal of the American Thyroid Association.

[7]  K. Hussain,et al.  Idiopathic postprandial hyperinsulinaemic hypoglycaemia , 2016, Journal of pediatric endocrinology & metabolism : JPEM.

[8]  M. Mcdermott,et al.  Novel Management of Insulin Autoimmune Syndrome with Rituximab and Continuous Glucose Monitoring. , 2016, The Journal of clinical endocrinology and metabolism.

[9]  A. Ismail.  Insulin analogues as a new example of interference in insulin assays , 2016, Annals of Clinical Biochemistry.

[10]  A. Dayaldasani,et al.  Cross-reactivity of insulin analogues with three insulin assays , 2015, Annals of clinical biochemistry.

[11]  Min-Seon Kim,et al.  Clinical Features and Causes of Endogenous Hyperinsulinemic Hypoglycemia in Korea , 2015, Diabetes & metabolism journal.

[12]  A. Vella,et al.  69-year-old man with recurrent episodes of confusion and diaphoresis. , 2013, Mayo Clinic proceedings.

[13]  E. Roh,et al.  Two Cases of Methimazole-Induced Insulin Autoimmune Syndrome in Graves' Disease , 2013, Endocrinology and metabolism.

[14]  Y. Uchigata,et al.  Insulin Autoimmune Syndrome (Hirata Disease) , 2011 .

[15]  P. Cryer,et al.  Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline. , 2009, The Journal of clinical endocrinology and metabolism.

[16]  S. O’Rahilly,et al.  Hypoglycemia due to an Insulin Binding Antibody in a Patient with an IgA-κ Myeloma , 2007 .

[17]  S. O’Rahilly,et al.  Hypoglycemia due to an insulin binding antibody in a patient with an IgA-kappa myeloma. , 2007, The Journal of clinical endocrinology and metabolism.

[18]  K. Park,et al.  Association of HLA-DR and -DQ genes with Graves disease in Koreans. , 2005, Human immunology.

[19]  A. Avenell,et al.  Antithyroid drug regimen for treating Graves' hyperthyroidism. , 2005, The Cochrane database of systematic reviews.

[20]  L. Sobrinho,et al.  Hypoglycaemia due to insulin autoimmune syndrome: report of two cases with characterisation of HLA alleles and insulin autoantibodies. , 2001, European journal of endocrinology.

[21]  K. Tadokoro,et al.  Differential Immunogenetic Determinants of Polyclonal Insulin Autoimmune Syndrome (Hirata's Disease) and Monoclonal Insulin Autoimmune Syndrome , 1995, Diabetes.

[22]  Y. Omori,et al.  A novel concept of type VII hypersensitivity introduced by insulin autoimmune syndrome (Hirata's disease) , 1995, Autoimmunity.

[23]  S. Matsushita,et al.  Allele specificity of structural requirement for peptides bound to HLA- DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome , 1994, The Journal of experimental medicine.

[24]  Y. Omori,et al.  Insulin autoimmune syndrome (Hirata disease): clinical features and epidemiology in Japan. , 1994, Diabetes research and clinical practice.

[25]  M. Ranney,et al.  Beyond the bedside: Clinicians as guardians of public health, medicine and science , 2020, The American Journal of Emergency Medicine.

[26]  Y. Hirata,et al.  Insulin autoimmune syndrome is the third leading cause of spontaneous hypoglycemic attacks in Japan. , 1990, Diabetes research and clinical practice.

[27]  W. Blackard,et al.  Characterization of circulating insulin and proinsulin-binding antibodies in autoimmune hypoglycemia. , 1979, The Journal of clinical investigation.